Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer

Clinical trial NCT02087241 · TERMINATED

Trial details

NCT number: NCT02087241
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer

Start date: 2014-03-01
Primary completion: 2015-06-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.